Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Board Committee Changes

27th Jan 2015 14:09

RNS Number : 2739D
GlaxoSmithKline PLC
27 January 2015
 



GlaxoSmithKline plc (the "Company")

Board Committee changes

 

GSK announces that Sir Philip Hampton has been appointed Chairman of the Nominations Committee (the "Committee") with effect from today, replacing Sir Christopher Gent, who will continue to serve as a member of the Committee for the remainder of his tenure on the Board.

 

In addition, Ms Lynn Elsenhans has also been appointed a member of the Committee, effective today.

 

The membership of the Nominations Committee is now:

 

Committee Chairman

 

Sir Philip Hampton

Chairman Designate

Members

Sir Christopher Gent

Chairman

Professor Sir Roy Anderson

Scientific & Medical Expert

Lynn Elsenhans

Independent Non Executive Director

Judy Lewent

Audit & Risk Committee Chairman

Sir Deryck Maughan

Senior Independent Director

Tom de Swaan

Remuneration Committee Chairman

 

V A Whyte

Company Secretary

 

27 January 2015

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAPKODKQBKDODB

Related Shares:

Glaxosmithkline
FTSE 100 Latest
Value8,632.33
Change89.77